Pay in 4 interest-free payments of $6.71 Learn more
Ships within 48 hours · Estimated delivery Sep 12 - Sep 17
Emerging Roles of the Human Solute Carrier 22 Family
The funnel plot exhibited a symmetrical distribution, indicating no publication bias, supported by Eggers test (p = 0.53) and Beggs test (p = 1.0), with no imputed studies found using the trim and fill model
Regulatory risks associated with inspectional findings at API manufacturing facilities in China or India could disrupt supply chains with significant consequences for finished drug manufacturers that have limited qualified API sources
A 2024 study published in JAMA Ophthalmology found that semaglutide users faced a higher risk of developing NAION when treated for diabetes or obesity
Andrew Hardaway, Ph.D
What the study found Patients who went on the weight-loss drugs and then stopped them regained their entire baseline weight on average around 20 months after they stopped taking the drugs
US$ 23.72
US$ 23.08
US$ 24.83
US$ 29.16
